
Vijaypd Ceutical Limited
About Vijaypd Ceutical Limited
Data last updated:
Vijaypd Ceutical Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the manufacturing segment of the paper and packaging sector. It was incorporated on 19 March 2024.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L21001MH2024PLC421713. It is a listed company as per MCA records. Its shares are listed on NSE: VIJAYPD.
The company has an authorised share capital of ₹20 Cr and a paid-up capital of ₹19.53 Cr. It is led by directors including Samit Madhukar Shah (Managing Director) and Rahul Jitendra Shah (Whole-Time Director).
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Mumbai, Maharashtra.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹100.23 Cr. For the same year it recorded a net profit of ₹5.02 Cr (net margin 5%) and EBITDA of ₹4.66 Cr (EBITDA margin 4.6%). The net worth stands at ₹52.49 Cr. Total assets are valued at ₹89.69 Cr.
As per MCA filings, the company has open charges of ₹29.25 Cr and satisfied charges of ₹12.68 Cr on record. The company has 1 deal on record (1 ipo); the latest was in October 2025.
Company details
CIN history
Vijaypd Ceutical has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L21001MH2024PLC421713, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L21001MH2024PLC421713 | Current |
| U21001MH2024PLC421713 | Previous |
| U46497MH2024PLC421713 | Previous |
Contact details
Vijaypd Ceutical Limited's registered office is in Goregaon West, Maharashtra.
- Registered AddressDevraj Bldg A1 1st Floor, S V Road Goregaon, Mumbai, Maharashtra, India – 400104
- IndustryPaper, Manufacturing, Paper & Paper Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Vijaypd Ceutical Limited
FY 2025-26 filings availableVijaypd Ceutical Limited reported revenue of ₹100.23 Cr for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedFinancial summary ₹ Cr
| Metrics | FY 2025-26 |
|---|---|
| Income statement | |
| Revenue | 100 |
| EBITDA | 4.66 |
| EBITDA margin | +4.7% |
| Profit before tax | 6.47 |
| Net profit | 5.02 |
| Net profit margin | +5.0% |
| EPS (₹) | 2.56 |
| Balance sheet | |
| Total assets | 89.69 |
| Net worth | 52.49 |
| Total debt | 36.71 |
| Cash & bank | 17.52 |
| Net working capital | 65.57 |
| Cash flow | |
| Cash from operations | (8.61) |
| Cash from investing | (13.33) |
| Cash from financing | 28.28 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 98.96 | 100 | 59.21 | 51.09 |
| Revenue growth | -1.3% | +69.3% | +15.9% | - |
| EBITDA | 4.71 | 8.42 | 4.87 | 1.31 |
| EBITDA margin | +4.8% | +8.4% | +8.2% | +2.6% |
| Profit before tax | 6.52 | 6.40 | 2.77 | 0.34 |
| Net profit | 5.07 | 4.71 | 1.66 | 0.17 |
| Net profit margin | +5.1% | +4.7% | +2.8% | +0.3% |
| EPS (₹) | 2.59 | 3.36 | 16.50 | 0.00 |
| Balance sheet | ||||
| Total assets | 86.79 | 54.32 | 31.25 | 30.71 |
| Net worth | 52.54 | 32.42 | 6.59 | 4.93 |
| Total debt | 33.67 | 21.77 | 24.45 | 25.57 |
| Cash & bank | 17.33 | 3.10 | 13.92 | 0.07 |
| Net working capital | 64.12 | 43.30 | 27.85 | 13.10 |
| Cash flow | ||||
| Cash from operations | (7.32) | (34.50) | - | - |
| Cash from investing | (12.17) | (9.72) | - | - |
| Cash from financing | 25.37 | 47.32 | - | - |
Financial Statements
| Particulars | FY 2025-26 |
|---|---|
| Revenue | 100 |
| Other income | 4.12 |
| Total expenses | 95.57 |
| Employee cost | 2.32 |
| EBITDA | 4.66 |
| EBITDA margin | +4.7% |
| Depreciation | 0.65 |
| Interest | 1.66 |
| Profit before tax | 6.47 |
| Tax | 1.46 |
| Net profit | 5.02 |
| Net profit margin | +5.0% |
| EPS (₹) | 2.56 |
| Particulars | FY 2025-26 |
|---|---|
| Equity & liabilities | |
| Share capital | 19.53 |
| Reserves & surplus | 32.96 |
| Shareholders' funds (net worth) | 52.49 |
| Minority interest | (0.08) |
| Secured loans | 28.06 |
| Unsecured loans | 8.65 |
| Total debt | 36.71 |
| Total liabilities | 89.69 |
| Assets | |
| Gross block | 10.48 |
| Net block | 9.21 |
| Capital work in progress | 1.66 |
| Investments | 0.26 |
| Inventories | 12.46 |
| Sundry debtors | 30.59 |
| Cash & bank balances | 17.52 |
| Loans & advances | 14.96 |
| Total current assets | 75.53 |
| Total current liabilities | 9.96 |
| Net working capital | 65.57 |
| Total assets | 89.69 |
| Particulars | FY 2025-26 |
|---|---|
| Opening cash | 6.41 |
| Net cash from operating activities | (8.61) |
| Net cash from investing activities | (13.33) |
| Net cash from financing activities | 28.28 |
| Net change in cash | 6.34 |
| Closing cash | 17.52 |
| Particulars | FY 2025-26 |
|---|---|
| Growth | |
| PBT growth | +9997.0% |
| Profitability & leverage | |
| Net income margin | +5.0% |
| Return on capital employed | +9.1% |
| Return on net worth | +9.5% |
| Debt / equity | 0.70 |
| Long-term debt / equity | 0.08 |
| Interest cover | 41.40 |
| Efficiency & per share | |
| Fixed asset turnover | 9.56 |
| Inventory turnover | 8.04 |
| Debtors turnover | 3.28 |
| EPS (₹) | 2.56 |
| Dividend per share (₹) | 0.00 |
| Book value per share (₹) | 26.88 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Revenue | 98.96 | 100 | 59.21 | 51.09 |
| Revenue growth | -1.3% | +69.3% | +15.9% | - |
| Other income | 4.03 | 0.75 | 0.01 | 1.82 |
| Total expenses | 94.25 | 91.81 | 54.34 | 49.78 |
| Employee cost | 2.24 | 1.52 | 0.91 | 0.98 |
| EBITDA | 4.71 | 8.42 | 4.87 | 1.31 |
| EBITDA margin | +4.8% | +8.4% | +8.2% | +2.6% |
| Depreciation | 0.62 | 0.62 | 0.35 | 0.43 |
| Interest | 1.60 | 2.15 | 1.76 | 2.36 |
| Profit before tax | 6.52 | 6.40 | 2.77 | 0.34 |
| Tax | 1.46 | 1.69 | 1.12 | 0.17 |
| Net profit | 5.07 | 4.71 | 1.66 | 0.17 |
| Net profit margin | +5.1% | +4.7% | +2.8% | +0.3% |
| EPS (₹) | 2.59 | 3.36 | 16.50 | 0.00 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Equity & liabilities | ||||
| Share capital | 19.53 | 14.03 | 1.00 | 0.00 |
| Reserves & surplus | 33.01 | 18.39 | 5.59 | 4.93 |
| Shareholders' funds (net worth) | 52.54 | 32.42 | 6.59 | 4.93 |
| Secured loans | 26.52 | 21.77 | 9.93 | 7.06 |
| Unsecured loans | 7.15 | 0.00 | 14.52 | 18.51 |
| Total debt | 33.67 | 21.77 | 24.45 | 25.57 |
| Total liabilities | 86.79 | 54.32 | 31.25 | 30.71 |
| Assets | ||||
| Gross block | 9.95 | 9.36 | 4.06 | 4.04 |
| Net block | 8.72 | 8.74 | 2.43 | 2.73 |
| Capital work in progress | 1.66 | 0.11 | 0.00 | 0.00 |
| Investments | 2.09 | 0.25 | 0.15 | 0.16 |
| Inventories | 11.44 | 11.54 | 4.11 | 3.95 |
| Sundry debtors | 30.00 | 23.80 | 11.11 | 8.74 |
| Cash & bank balances | 17.33 | 3.10 | 13.92 | 0.07 |
| Loans & advances | 14.86 | 7.82 | 0.73 | 2.50 |
| Total current assets | 73.63 | 46.26 | 29.87 | 15.26 |
| Total current liabilities | 9.51 | 2.96 | 2.02 | 2.16 |
| Net working capital | 64.12 | 43.30 | 27.85 | 13.10 |
| Total assets | 86.79 | 54.32 | 31.25 | 30.71 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Opening cash | 3.10 | 0.00 | - | - |
| Net cash from operating activities | (7.32) | (34.50) | - | - |
| Net cash from investing activities | (12.17) | (9.72) | - | - |
| Net cash from financing activities | 25.37 | 47.32 | - | - |
| Net change in cash | 5.88 | 3.10 | - | - |
| Closing cash | 17.33 | 3.10 | - | - |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Growth | ||||
| Sales growth | -1.3% | +69.3% | +15.9% | - |
| EBITDA growth | -44.1% | +72.9% | +271.8% | - |
| PBT growth | +1.9% | +131.1% | +714.7% | +9997.0% |
| Net income growth | +7.6% | +183.7% | +876.5% | - |
| Revenue CAGR (3Y) | +24.7% | - | - | - |
| EBITDA CAGR (3Y) | +53.2% | - | - | - |
| Profitability & leverage | ||||
| Net income margin | +5.1% | +4.7% | +2.8% | +0.3% |
| Return on capital employed | +11.5% | +20.0% | +14.7% | +8.8% |
| Return on net worth | +11.9% | +24.2% | +28.7% | +3.7% |
| Debt / equity | 0.65 | 1.18 | 4.34 | 5.19 |
| Long-term debt / equity | 0.06 | 0.03 | 0.14 | 0.16 |
| Interest cover | 39.12 | 27.56 | 38.94 | 268.18 |
| Efficiency & per share | ||||
| Fixed asset turnover | 10.25 | 14.94 | 14.62 | 12.65 |
| Inventory turnover | 8.61 | 12.81 | 14.69 | 12.93 |
| Debtors turnover | 3.68 | 5.74 | 5.97 | 5.85 |
| EPS (₹) | 2.59 | 3.36 | 16.50 | 0.00 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 26.90 | 23.11 | 65.91 | 0.00 |
To see the full year-wise statements and ratios of Vijaypd Ceutical Limited, buy the company report.
Board of directors of Vijaypd Ceutical Limited
Vijaypd Ceutical has 6 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pulkit Gopal Prasad Agrawal Also directs: Valugenius Advisors LLP | Director | 29 Oct 2024 | 2 Years 0 Months | Current |
| Nikita Hemanshu Pedhdiya | Director | 05 Oct 2024 | 2 Years 0 Months | Current |
| Rahul Jitendra Shah Also directs: Saltiva Pharmaceuticals Private Limited | Whole-Time Director | 01 May 2025 | 1 Years 6 Months | Current |
| Bhavin Dhirendra Shah Also directs: Saltiva Pharmaceuticals Private Limited | Whole-Time Director | 19 Mar 2024 | 2 Years 7 Months | Current |
| Narendra Nagindas Shah Also directs: Revomed Private Limited | Director | 19 Mar 2024 | 2 Years 7 Months | Current |
| Samit Madhukar Shah Also directs: Revomed Private Limited, Saltiva Pharmaceuticals Private Limited | Managing Director | 19 Mar 2024 | 2 Years 7 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Aug 2026 | 101394766 | Hdfc Bank Limited | ₹4.85 Cr | Open | |
| 14 Oct 2024 | 100999022 | Hdfc Bank Limited | ₹24.4 Cr | Open | |
| 19 Mar 2024 | 100901570 | Axis Bank Limited | ₹12.68 Cr | Satisfied |
To see the full charge records of Vijaypd Ceutical Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Vijaypd Ceutical Limited has 1 deal on record (1 ipo); the latest was in October 2025.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2025 | IPO | ₹19.25 Cr | Investors: Public Market Investors |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Vijaypd Ceutical Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vijaypd Ceutical Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Vijaypd Ceutical Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Vijaypd Ceutical Limited has 17 board changes on record since 2024: 6 appointments and 11 cessations. The latest: Rahul Jitendra Shah was appointed as Whole-Time Director on 01 May 2025.
13 earlier events are in the company report.
Frequently asked questions
Vijaypd Ceutical is an active public limited company based in Mumbai, Maharashtra, India. The company works in manufacturing, within the paper industry. It was incorporated on 19 March 2024 (2+ years old) and is registered under CIN L21001MH2024PLC421713. Listed on NSE: VIJAYPD.
Vijaypd Ceutical reported revenue of ₹100.23 Cr for FY 2025-26 based on consolidated financials.
Vijaypd Ceutical has 6 current directors:
- Samit Madhukar Shah - Managing Director
- Rahul Jitendra Shah - Whole-Time Director
- Bhavin Dhirendra Shah - Whole-Time Director
- Pulkit Gopal Prasad Agrawal - Director
- Nikita Hemanshu Pedhdiya - Director
- Narendra Nagindas Shah - Director
The latest financial statements of Vijaypd Ceutical on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 25 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Vijaypd Ceutical is L21001MH2024PLC421713. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Vijaypd Ceutical is a listed company as per MCA records. Its shares are listed on NSE (symbol: VIJAYPD).
Vijaypd Ceutical was incorporated on 19 March 2024, making it 2+ years old. It is registered with the Registrar of Companies, Mumbai.
Vijaypd Ceutical has 1 deal on record (1 ipo); the latest was in October 2025.
Rahul Jitendra Shah was appointed as Whole-Time Director on 01 May 2025. Pulkit Gopal Prasad Agrawal ceased to be Additional Director on 21 Nov 2024. Pulkit Gopal Prasad Agrawal was appointed as Director on 29 Oct 2024. Vijaypd Ceutical has 17 board changes on record in total.
The registered office of Vijaypd Ceutical is at Devraj Bldg A1 1st Floor, S V Road Goregaon, Mumbai, Maharashtra, India – 400104.

